SYNER-KINASE is a medication used in the medical field for its fibrinolytic properties, which means it helps in breaking down blood clots. It is commonly utilized in the treatment of acute myocardial infarction (heart attack), pulmonary embolism, and deep vein thrombosis, among other conditions where blood clots pose a significant health risk. The active ingredient in SYNER-KINASE works by activating plasminogen, which is a precursor to plasmin, the enzyme responsible for clot breakdown. This process helps to restore normal blood flow in the affected vessels, thereby reducing the risk of complications associated with blood clots. SYNER-KINASE is typically administered under medical supervision, often in a hospital setting, to ensure the safety and efficacy of the treatment.